Company Overview More
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated with inherited risk of 12 types of cancers, including the BRCA1/2 genes for hereditary breast, ovarian, colorectal, endometrial, pancreatic, and other cancer syndromes, as well as for the five genes associated with Lynch syndrome. The company also provides Resura, a noninvasive prenatal test for families at risk for rare single gene disorders; and Preecludia, a preeclampsia rule-out test. In addition, it offers anatomic and molecular pathology tests, and COVID-19 PCR testing services, as well as test products that includes chromosomal microarray for pregnancy loss, which evaluates the genetic cause of miscarriage; maternal serum screening for chromosomal disorders; and preimplantation genetic testing for use with artificial reproductive technologies. Further, the company develops therapeutic solutions for gastrointestinal-related disorders, such as PGN-001, PGN-300, PGN-600, and PGN-OB2. It also owns and operates laboratory. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California.
CEO: Mohanty, Aditya P.
Market: NASDAQ
Futu Hot List
USHKCN
Trade HeatSearch HeatNews Heat
SymbolLatest Price% Chg

Loading...

Moomoo > Quotes > PROG Progenity > Detailed Quotes

PROG Progenity

3.640-0.110-2.93%
Close 11/26 16:54 ET
3.540-0.1-2.75%
Post Mkt Price 11/26 16:57 ET
High
3.780
Open
3.540
Turnover
77.25M
Low
3.434
Prev.Close
3.750
Volume
21.28M
Market Cap
596.05M
P/E(TTM)
Loss
52Wk High
7.860
Shares
163.75M
P/E
Loss
52Wk Low
0.657
H Mkt Cap
409.18M
Bid-Ask Ratio
-94.80%
Historical High
15.920
H Shares
112.41M
Vol. Ratio
0.52
Historical Low
0.657
Dividend TTM
--
Div Yield TTM
--
P/B
-3.37
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
18.93%
Amplitude
9.22%
Avg Price
3.630
Min Trading Unit
1
Float Market Cap
409.18M
Bid-Ask Ratio
-94.80%
Historical High
15.920
Float
112.41M
Vol. Ratio
0.52
Historical Low
0.657
Dividend TTM
--
P/B
-3.37
Dividend LFY
--
Turnover Ratio
18.93%
Amplitude
9.22%
Avg Price
3.630
Min Trading Unit
1
Price Forecast

Loading...

News